Journal
TRENDS IN BIOTECHNOLOGY
Volume 25, Issue 9, Pages 425-432Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2007.07.002
Keywords
-
Categories
Ask authors/readers for more resources
The selection of high-producing mammalian cell lines represents a bottleneck in process development for the production of biopharmaceuticals. Traditional methods are time consuming (development times often exceed six months) and significantly limited by the number of clones that can be feasibly screened. The market for therapeutic proteins is set to double by 2010, so there is an increasing need to develop methods for the selection of mammalian cell lines stably expressing recombinant products at high levels in an efficient, cost-effective and high-throughput manner. Alternatives include higher throughput methods based on flow-cytometric screening and recently developed automated systems for the selection of high-producing cell lines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available